Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000950170-25-107056
Filing Date
2025-08-12
Accepted
2025-08-12 11:56:47
Documents
2

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G  
1 primary_doc.xml SCHEDULE 13G 8532
2 EX-99.A ck0000000000-ex99_a.pdf EX-99.A 134636
  Complete submission text file 0000950170-25-107056.txt   195887
Mailing Address 7555 INNOVATION WAY MASON OH 45040
Business Address 7555 INNOVATION WAY MASON OH 45040 513-755-4100
AtriCure, Inc. (Subject) CIK: 0001323885 (see all company filings)

EIN.: 341940305 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G | Act: 34 | File No.: 005-81467 | Film No.: 251205363
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)

Mailing Address 1 ELIZABETH STREET SYDNEY, NSW 2000 Australia 2000
Business Address 1 ELIZABETH STREET SYDNEY, NSW 2000 Australia 2000 212.231.1000
MACQUARIE GROUP LTD (Filed by) CIK: 0001418333 (see all company filings)

EIN.: 000000000 | State of Incorp.: C3 | Fiscal Year End: 1231
Type: SCHEDULE 13G